| Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels M Kankaanpää, HR Lehto, JP Pärkkä, M Komu, A Viljanen, ... The Journal of Clinical Endocrinology & Metabolism 91 (11), 4689-4695, 2006 | 400 | 2006 |
| Bromocriptine: a novel approach to the treatment of type 2 diabetes. H Pijl, S Ohashi, M Matsuda, Y Miyazaki, A Mahankali, V Kumar, R Pipek, ... Diabetes care 23 (8), 1154-1161, 2000 | 334 | 2000 |
| Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy H Tuunanen, E Engblom, A Naum, K Någren, M Scheinin, B Hesse, ... Circulation 118 (12), 1250-1258, 2008 | 324 | 2008 |
| Myocardial, perivascular, and epicardial fat P Iozzo Diabetes care 34 (Supplement_2), S371-S379, 2011 | 323 | 2011 |
| Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure H Tuunanen, E Engblom, A Naum, K Någren, B Hesse, KEJ Airaksinen, ... Circulation 114 (20), 2130-2137, 2006 | 270 | 2006 |
| Independent influence of age on basal insulin secretion in nondiabetic humans P Iozzo, H Beck-Nielsen, M Laakso, ULF Smith, H Yki-Järvinen, ... The Journal of Clinical Endocrinology & Metabolism 84 (3), 863-868, 1999 | 270 | 1999 |
| Pathophysiology of prediabetes E Ferrannini, A Gastaldelli, P Iozzo Medical Clinics 95 (2), 327-339, 2011 | 225 | 2011 |
| Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance P Iozzo, P Chareonthaitawee, D Dutka, DJ Betteridge, E Ferrannini, ... Diabetes 51 (10), 3020-3024, 2002 | 211 | 2002 |
| Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes R Lautamaki, R Borra, P Iozzo, M Komu, T Lehtimaki, M Salmi, S Jalkanen, ... American Journal of Physiology-Endocrinology and Metabolism 291 (2), E282-E290, 2006 | 209 | 2006 |
| Increased brain fatty acid uptake in metabolic syndrome A Karmi, P Iozzo, A Viljanen, J Hirvonen, BA Fielding, K Virtanen, ... Diabetes 59 (9), 2171-2177, 2010 | 200 | 2010 |
| The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment … A Latva-Rasku, MJ Honka, J Kullberg, N Mononen, T Lehtimäki, J Saltevo, ... Diabetes care 42 (5), 931-937, 2019 | 196 | 2019 |
| Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals P Iozzo, M Bucci, A Roivainen, K Någren, MJ Järvisalo, J Kiss, L Guiducci, ... Gastroenterology 139 (3), 846-856. e6, 2010 | 179 | 2010 |
| Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance APM Viljanen, P Iozzo, R Borra, M Kankaanpaa, A Karmi, R Lautamaki, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 50-55, 2009 | 172 | 2009 |
| Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids M Orešič, T Hyötyläinen, A Kotronen, P Gopalacharyulu, H Nygren, ... Diabetologia 56, 2266-2274, 2013 | 165 | 2013 |
| Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. M Pendergrass, J Koval, C Vogt, H Yki-Jarvinen, P Iozzo, R Pipek, ... Diabetes 47 (3), 387-394, 1998 | 156 | 1998 |
| The association of micronucleus frequency with obesity, diabetes and cardiovascular disease MG Andreassi, R Barale, P Iozzo, E Picano Mutagenesis 26 (1), 77-83, 2011 | 152 | 2011 |
| Contribution of glucose tolerance and gender to cardiac adiposity P Iozzo, R Lautamaki, R Borra, HR Lehto, M Bucci, A Viljanen, J Parkka, ... The Journal of Clinical Endocrinology & Metabolism 94 (11), 4472-4482, 2009 | 146 | 2009 |
| Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study KA Virtanen, P Iozzo, K Hällsten, R Huupponen, R Parkkola, ... Diabetes 54 (9), 2720-2726, 2005 | 142 | 2005 |
| Effects of insulin on brain glucose metabolism in impaired glucose tolerance J Hirvonen, KA Virtanen, L Nummenmaa, JC Hannukainen, MJ Honka, ... Diabetes 60 (2), 443-447, 2011 | 134 | 2011 |
| Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study R Lautamaki, KEJ Airaksinen, M Seppänen, J Toikka, M Luotolahti, ... Diabetes 54 (9), 2787-2794, 2005 | 133 | 2005 |
